- Home
- BMR vs VNRX Comparison
BMR vs VNRX Comparison
Compare BMR & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- VNRX
- Stock Information
- Founded
- BMR 2009
- VNRX N/A
- Country
- BMR Israel
- VNRX United States
- Employees
- BMR N/A
- VNRX N/A
- Industry
- BMR Computer Software: Prepackaged Software
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BMR Technology
- VNRX Health Care
- Exchange
- BMR Nasdaq
- VNRX Nasdaq
- Market Cap
- BMR 59.3M
- VNRX 59.6M
- IPO Year
- BMR 2023
- VNRX N/A
- Fundamental
- Price
- BMR $3.87
- VNRX $0.63
- Analyst Decision
- BMR
- VNRX Strong Buy
- Analyst Count
- BMR 0
- VNRX 4
- Target Price
- BMR N/A
- VNRX $4.17
- AVG Volume (30 Days)
- BMR 716.0K
- VNRX 154.8K
- Earning Date
- BMR 08-06-2024
- VNRX 11-14-2024
- Dividend Yield
- BMR N/A
- VNRX N/A
- EPS Growth
- BMR N/A
- VNRX N/A
- EPS
- BMR N/A
- VNRX N/A
- Revenue
- BMR $2,955,000.00
- VNRX $1,285,827.00
- Revenue This Year
- BMR $21.52
- VNRX $71,446.31
- Revenue Next Year
- BMR N/A
- VNRX N/A
- P/E Ratio
- BMR N/A
- VNRX N/A
- Revenue Growth
- BMR 2.25
- VNRX 97.50
- 52 Week Low
- BMR $1.41
- VNRX $0.43
- 52 Week High
- BMR $34.94
- VNRX $1.23
- Technical
- Relative Strength Index (RSI)
- BMR 48.56
- VNRX 48.89
- Support Level
- BMR $4.25
- VNRX $0.61
- Resistance Level
- BMR $4.23
- VNRX $0.65
- Average True Range (ATR)
- BMR 0.75
- VNRX 0.05
- MACD
- BMR -0.11
- VNRX 0.00
- Stochastic Oscillator
- BMR 11.69
- VNRX 38.10
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.